Passage of the Inflation Reduction Act (2022) has meant several changes to Medicare Part D, including these most frequently mentioned: 2023: Insulin co-pay capped at $35 for 30 day supply. 2024: Catastrophic Coverage Stage cost sharing eliminated. 2025: Annual Out-of-Pocket Drug cost sharing capped at $2000. 2026: Medicare and drug companies, for the first time, […]